Status:
COMPLETED
The Effect of Probiotics on the Improvement of Intestinal and Immune Function
Lead Sponsor:
Wecare Probiotics Co., Ltd.
Conditions:
Intestinal and Immune Function Improved
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Evaluate the effectiveness and safety of Lactobacillus delbrueckii subsp. bulgaricus LB42 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.
Eligibility Criteria
Inclusion
- Age 18-45 years
- Willing to undergo 3 follow-up visits during the intervention period
- Willing to provide 2 blood, urine, and stool samples during the intervention period
- Willing to self-administer one of the probiotics/placebo once daily during the intervention period
- Good eyesight, able to read and write, and can wear glasses
- Have good hearing and be able to hear and understand all instructions during the intervention
Exclusion
- Suffering from digestive disorders, mainly gastrointestinal disorders (celiac disease, ulcerative colitis, Crohn's disease)
- Has a severe neurological condition (epilepsy, stroke, severe head trauma, meningitis within the past 10 years, brain surgery, brain tumor, prolonged coma - excluding general anesthesia)
- Has received/is receiving treatment for the following psychiatric disorders: alcohol/drug/substance abuse dependence, schizophrenia, psychosis, bipolar disorder
- Take medication for depression or low mood
- Suffering from internal organ failure (heart, liver, or kidney failure, etc.)
- Radiotherapy or chemotherapy in the past
- Surgery/procedure under general anesthesia within the past three years, or planned to undergo a procedure/procedure under general anesthesia within the next 3 months during this trial
- Have had hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06873438
Start Date
March 1 2025
End Date
August 15 2025
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xu fei
Zhengzhou, Henan, China, 210095